Stay updated on RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial

Sign up to get notified when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:26:25.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the study data related to a clinical trial comparing the efficacy of RTXM83 (rituximab biosimilar) vs reference rituximab (MabThera®) in patients with Diffuse Large B-cell Lymphoma (DLBCL) when combined with CHOP chemotherapy.
    Difference
    0.1%
    Check dated 2024-06-06T14:29:10.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a more detailed description, now stating that researchers look for people who fit specific eligibility criteria, such as general health condition or prior treatments. This change provides a clearer understanding of the criteria used to select participants for clinical research.
    Difference
    23%
    Check dated 2024-05-22T21:10:02.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T21:59:22.000Z thumbnail image

Stay in the know with updates to RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.